Inovio Biomedical Corp (INO) reported third quarter net loss attributable to Inovio Biomedical of $2.95 million, compared to net loss attributable to Inovio Biomedical of $2.34 million last year. Loss per share was $0.03, narrower than $0.05 in the prior year quarter.
Total revenue grew to $3.65 million from $455 thousand in the same quarter last year.
For comments and feedback: editorial@rttnews.com